Concepts (294)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 18 | 2024 | 460 | 4.470 |
Why?
|
| beta-Glucans | 5 | 2023 | 11 | 3.180 |
Why?
|
| Drug Delivery Systems | 15 | 2024 | 277 | 3.060 |
Why?
|
| Ionic Liquids | 4 | 2023 | 20 | 2.790 |
Why?
|
| Graphite | 9 | 2023 | 64 | 2.660 |
Why?
|
| Biocompatible Materials | 7 | 2024 | 108 | 2.050 |
Why?
|
| Liposomes | 3 | 2024 | 132 | 1.790 |
Why?
|
| Antineoplastic Agents | 6 | 2023 | 1019 | 1.790 |
Why?
|
| Gene Transfer Techniques | 5 | 2024 | 53 | 1.750 |
Why?
|
| Quantum Dots | 10 | 2017 | 38 | 1.720 |
Why?
|
| Neoplasms | 7 | 2023 | 1377 | 1.660 |
Why?
|
| Drug Carriers | 8 | 2024 | 174 | 1.600 |
Why?
|
| Excipients | 2 | 2024 | 25 | 1.600 |
Why?
|
| Biosensing Techniques | 4 | 2024 | 136 | 1.550 |
Why?
|
| Melanoma | 2 | 2023 | 110 | 1.420 |
Why?
|
| Stomach Neoplasms | 2 | 2023 | 241 | 1.360 |
Why?
|
| Skin | 4 | 2024 | 187 | 1.330 |
Why?
|
| Diagnostic Imaging | 5 | 2014 | 53 | 1.300 |
Why?
|
| Nanostructures | 5 | 2023 | 161 | 1.290 |
Why?
|
| Animals | 35 | 2024 | 16992 | 1.280 |
Why?
|
| Administration, Cutaneous | 3 | 2024 | 48 | 1.240 |
Why?
|
| Exosomes | 2 | 2022 | 126 | 1.230 |
Why?
|
| Fibrosis | 4 | 2024 | 169 | 1.220 |
Why?
|
| Pulmonary Fibrosis | 3 | 2024 | 38 | 1.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2024 | 152 | 1.180 |
Why?
|
| Mice | 23 | 2024 | 6644 | 1.140 |
Why?
|
| Electrochemical Techniques | 2 | 2024 | 32 | 1.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2024 | 32 | 1.030 |
Why?
|
| Apoptosis | 4 | 2024 | 1568 | 1.010 |
Why?
|
| Sulfonamides | 2 | 2024 | 91 | 1.000 |
Why?
|
| Rheology | 3 | 2024 | 51 | 1.000 |
Why?
|
| Phototherapy | 4 | 2023 | 25 | 0.990 |
Why?
|
| Photochemotherapy | 3 | 2023 | 43 | 0.990 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 1869 | 0.950 |
Why?
|
| Humans | 46 | 2024 | 43102 | 0.900 |
Why?
|
| Point-of-Care Systems | 1 | 2024 | 35 | 0.860 |
Why?
|
| Skin Absorption | 1 | 2024 | 16 | 0.850 |
Why?
|
| Obesity | 3 | 2022 | 1151 | 0.850 |
Why?
|
| Lidocaine | 1 | 2024 | 16 | 0.850 |
Why?
|
| Emulsions | 1 | 2024 | 36 | 0.850 |
Why?
|
| Gels | 1 | 2024 | 45 | 0.840 |
Why?
|
| Biological Availability | 1 | 2024 | 116 | 0.840 |
Why?
|
| Petroleum | 1 | 2024 | 20 | 0.840 |
Why?
|
| Administration, Oral | 8 | 2024 | 260 | 0.810 |
Why?
|
| Cadherins | 1 | 2024 | 102 | 0.800 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 67 | 0.800 |
Why?
|
| Biomimetic Materials | 1 | 2023 | 24 | 0.790 |
Why?
|
| Angiotensins | 1 | 2022 | 10 | 0.780 |
Why?
|
| Lipids | 1 | 2024 | 256 | 0.760 |
Why?
|
| Nanotechnology | 4 | 2024 | 176 | 0.740 |
Why?
|
| Fatty Acids | 1 | 2023 | 134 | 0.740 |
Why?
|
| Carbon | 5 | 2023 | 128 | 0.720 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 760 | 0.700 |
Why?
|
| Leptin | 1 | 2022 | 118 | 0.700 |
Why?
|
| Iron | 1 | 2023 | 251 | 0.700 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 216 | 0.690 |
Why?
|
| Biological Products | 1 | 2022 | 91 | 0.660 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 178 | 0.650 |
Why?
|
| Bleomycin | 3 | 2024 | 20 | 0.630 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 94 | 0.630 |
Why?
|
| Boron Compounds | 2 | 2018 | 18 | 0.630 |
Why?
|
| Dietary Fats | 1 | 2019 | 117 | 0.590 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 224 | 0.570 |
Why?
|
| Polyethylene Glycols | 5 | 2023 | 108 | 0.550 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 495 | 0.540 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2017 | 15 | 0.540 |
Why?
|
| DNA | 2 | 2018 | 592 | 0.530 |
Why?
|
| Luminescence | 2 | 2014 | 31 | 0.530 |
Why?
|
| RNA, Small Interfering | 3 | 2023 | 436 | 0.510 |
Why?
|
| Spectroscopy, Near-Infrared | 3 | 2013 | 25 | 0.500 |
Why?
|
| Cell Line, Tumor | 9 | 2023 | 2676 | 0.470 |
Why?
|
| Micelles | 3 | 2014 | 36 | 0.440 |
Why?
|
| Water | 3 | 2024 | 316 | 0.410 |
Why?
|
| Gastrointestinal Tract | 3 | 2023 | 71 | 0.390 |
Why?
|
| Infrared Rays | 2 | 2024 | 21 | 0.380 |
Why?
|
| Lung | 3 | 2024 | 492 | 0.370 |
Why?
|
| Polymers | 4 | 2023 | 155 | 0.350 |
Why?
|
| Heparin | 3 | 2017 | 40 | 0.340 |
Why?
|
| Doxorubicin | 3 | 2022 | 97 | 0.320 |
Why?
|
| Adipose Tissue | 2 | 2021 | 182 | 0.300 |
Why?
|
| Erythrocytes | 2 | 2018 | 126 | 0.250 |
Why?
|
| Particle Size | 6 | 2024 | 272 | 0.240 |
Why?
|
| Surface Properties | 3 | 2016 | 160 | 0.240 |
Why?
|
| Light | 3 | 2023 | 185 | 0.240 |
Why?
|
| Taurocholic Acid | 2 | 2017 | 5 | 0.240 |
Why?
|
| Hydrogels | 2 | 2024 | 59 | 0.230 |
Why?
|
| Rats | 3 | 2024 | 3735 | 0.230 |
Why?
|
| Petrolatum | 1 | 2024 | 2 | 0.210 |
Why?
|
| Administration, Topical | 1 | 2024 | 39 | 0.210 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2024 | 7 | 0.210 |
Why?
|
| Viscosity | 1 | 2024 | 46 | 0.210 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2024 | 15 | 0.210 |
Why?
|
| Aniline Compounds | 1 | 2024 | 28 | 0.210 |
Why?
|
| Photosensitizing Agents | 2 | 2015 | 56 | 0.210 |
Why?
|
| Immunity, Mucosal | 1 | 2024 | 53 | 0.210 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2024 | 97 | 0.210 |
Why?
|
| Drug Stability | 1 | 2024 | 129 | 0.200 |
Why?
|
| Ketones | 1 | 2023 | 18 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 1766 | 0.200 |
Why?
|
| Cobalt | 1 | 2023 | 29 | 0.200 |
Why?
|
| Swine | 1 | 2024 | 212 | 0.200 |
Why?
|
| Docosahexaenoic Acids | 1 | 2023 | 19 | 0.200 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 127 | 0.200 |
Why?
|
| Fluorouracil | 1 | 2023 | 47 | 0.200 |
Why?
|
| Male | 6 | 2024 | 23409 | 0.200 |
Why?
|
| Glycerophospholipids | 1 | 2022 | 4 | 0.200 |
Why?
|
| Fluorescent Dyes | 1 | 2024 | 182 | 0.190 |
Why?
|
| Cell Line | 2 | 2017 | 1410 | 0.190 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2022 | 20 | 0.190 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 224 | 0.190 |
Why?
|
| Immunotherapy | 1 | 2024 | 144 | 0.190 |
Why?
|
| Cell Survival | 7 | 2017 | 945 | 0.190 |
Why?
|
| Caprylates | 1 | 2022 | 14 | 0.190 |
Why?
|
| Fibroblasts | 1 | 2024 | 281 | 0.190 |
Why?
|
| Bile Acids and Salts | 1 | 2022 | 37 | 0.180 |
Why?
|
| RNA Interference | 1 | 2023 | 247 | 0.180 |
Why?
|
| Intestinal Absorption | 2 | 2019 | 22 | 0.180 |
Why?
|
| RNA | 1 | 2024 | 266 | 0.180 |
Why?
|
| Choline | 1 | 2022 | 61 | 0.180 |
Why?
|
| Collagen | 1 | 2022 | 181 | 0.180 |
Why?
|
| Colon | 1 | 2022 | 120 | 0.180 |
Why?
|
| Hydrogen Bonding | 1 | 2021 | 144 | 0.180 |
Why?
|
| Oligopeptides | 2 | 2023 | 109 | 0.170 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 44 | 0.170 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 19 | 0.170 |
Why?
|
| Cell Communication | 1 | 2022 | 114 | 0.170 |
Why?
|
| Fullerenes | 1 | 2021 | 31 | 0.170 |
Why?
|
| Electricity | 1 | 2020 | 12 | 0.160 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 241 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2022 | 307 | 0.160 |
Why?
|
| Ultrasonography | 1 | 2020 | 135 | 0.160 |
Why?
|
| Cytokines | 1 | 2023 | 678 | 0.150 |
Why?
|
| Nanotubes, Carbon | 1 | 2021 | 87 | 0.150 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 117 | 0.150 |
Why?
|
| Tissue Distribution | 3 | 2017 | 240 | 0.150 |
Why?
|
| Hyaluronic Acid | 2 | 2017 | 36 | 0.150 |
Why?
|
| Antiviral Agents | 1 | 2021 | 195 | 0.150 |
Why?
|
| Liver | 1 | 2022 | 511 | 0.150 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 1081 | 0.150 |
Why?
|
| Eating | 1 | 2020 | 167 | 0.140 |
Why?
|
| Tissue Engineering | 2 | 2021 | 75 | 0.140 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 512 | 0.140 |
Why?
|
| Polylysine | 1 | 2018 | 9 | 0.140 |
Why?
|
| Transcription Factors | 1 | 2023 | 735 | 0.140 |
Why?
|
| Blood Coagulation | 1 | 2018 | 29 | 0.140 |
Why?
|
| Histamine | 1 | 2017 | 19 | 0.140 |
Why?
|
| Peptides | 1 | 2021 | 372 | 0.140 |
Why?
|
| Rats, Zucker | 1 | 2017 | 24 | 0.130 |
Why?
|
| Mice, Nude | 3 | 2013 | 408 | 0.130 |
Why?
|
| Immune Tolerance | 1 | 2017 | 68 | 0.130 |
Why?
|
| Quality of Life | 1 | 2022 | 616 | 0.130 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 230 | 0.130 |
Why?
|
| Leukemia | 1 | 2017 | 54 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 432 | 0.130 |
Why?
|
| Antigens, Viral | 1 | 2017 | 48 | 0.130 |
Why?
|
| Plasmids | 1 | 2018 | 244 | 0.130 |
Why?
|
| Heparin, Low-Molecular-Weight | 2 | 2013 | 9 | 0.120 |
Why?
|
| Hemoglobins | 1 | 2016 | 113 | 0.120 |
Why?
|
| Methacrylates | 1 | 2016 | 6 | 0.120 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 134 | 0.120 |
Why?
|
| Cross-Linking Reagents | 1 | 2016 | 51 | 0.120 |
Why?
|
| Deoxycholic Acid | 2 | 2012 | 8 | 0.120 |
Why?
|
| Chitosan | 1 | 2016 | 53 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 38 | 0.110 |
Why?
|
| Nanocapsules | 1 | 2015 | 19 | 0.110 |
Why?
|
| Chlorophyll | 1 | 2015 | 24 | 0.110 |
Why?
|
| Cadmium Compounds | 2 | 2014 | 7 | 0.110 |
Why?
|
| Polyethylene Terephthalates | 1 | 2014 | 2 | 0.110 |
Why?
|
| Selenium Compounds | 2 | 2014 | 11 | 0.110 |
Why?
|
| Tin Compounds | 1 | 2014 | 3 | 0.110 |
Why?
|
| Polytetrafluoroethylene | 1 | 2014 | 6 | 0.110 |
Why?
|
| Solar Energy | 1 | 2014 | 10 | 0.110 |
Why?
|
| Ferric Compounds | 1 | 2015 | 62 | 0.110 |
Why?
|
| Enzymes | 1 | 2014 | 35 | 0.110 |
Why?
|
| Electrodes | 1 | 2014 | 59 | 0.110 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2014 | 104 | 0.110 |
Why?
|
| Fluorescence | 2 | 2015 | 118 | 0.110 |
Why?
|
| Antibodies | 1 | 2014 | 144 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 1596 | 0.100 |
Why?
|
| Diet | 1 | 2020 | 826 | 0.100 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 68 | 0.100 |
Why?
|
| Materials Testing | 2 | 2024 | 101 | 0.100 |
Why?
|
| Biomedical Engineering | 1 | 2013 | 12 | 0.100 |
Why?
|
| Biomedical Technology | 1 | 2013 | 12 | 0.100 |
Why?
|
| Photochemistry | 1 | 2013 | 57 | 0.100 |
Why?
|
| Bivalvia | 1 | 2013 | 28 | 0.100 |
Why?
|
| Toxicity Tests | 1 | 2013 | 44 | 0.100 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2013 | 64 | 0.100 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 98 | 0.100 |
Why?
|
| Mitochondria | 1 | 2017 | 523 | 0.100 |
Why?
|
| Solubility | 1 | 2013 | 139 | 0.100 |
Why?
|
| Taxoids | 1 | 2013 | 50 | 0.100 |
Why?
|
| Dogs | 1 | 2013 | 204 | 0.100 |
Why?
|
| Gold | 1 | 2014 | 156 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 1723 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2013 | 347 | 0.090 |
Why?
|
| Indoles | 1 | 2013 | 187 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 587 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2012 | 122 | 0.090 |
Why?
|
| Female | 7 | 2024 | 24698 | 0.080 |
Why?
|
| Tellurium | 1 | 2010 | 5 | 0.080 |
Why?
|
| Nanospheres | 1 | 2010 | 7 | 0.080 |
Why?
|
| Whole Body Imaging | 1 | 2010 | 25 | 0.080 |
Why?
|
| Polyglycolic Acid | 1 | 2010 | 48 | 0.080 |
Why?
|
| Polyesters | 1 | 2010 | 28 | 0.080 |
Why?
|
| Vaccines | 2 | 2024 | 65 | 0.080 |
Why?
|
| Caco-2 Cells | 3 | 2017 | 64 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2010 | 112 | 0.080 |
Why?
|
| Time Factors | 1 | 2013 | 1857 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 306 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1455 | 0.070 |
Why?
|
| Delayed-Action Preparations | 2 | 2020 | 74 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2016 | 159 | 0.060 |
Why?
|
| Contrast Media | 2 | 2015 | 103 | 0.050 |
Why?
|
| HCT116 Cells | 1 | 2024 | 40 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2024 | 34 | 0.050 |
Why?
|
| HT29 Cells | 1 | 2024 | 60 | 0.050 |
Why?
|
| Silicon Dioxide | 1 | 2024 | 39 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2021 | 1604 | 0.050 |
Why?
|
| Benzophenones | 1 | 2023 | 11 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2023 | 32 | 0.050 |
Why?
|
| Ethers | 1 | 2023 | 21 | 0.050 |
Why?
|
| Serum Response Factor | 1 | 2023 | 10 | 0.050 |
Why?
|
| Genes, Switch | 1 | 2022 | 3 | 0.050 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2022 | 10 | 0.050 |
Why?
|
| rho-Associated Kinases | 1 | 2023 | 36 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 532 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2023 | 152 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 141 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 159 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2021 | 19 | 0.040 |
Why?
|
| Latin America | 1 | 2021 | 55 | 0.040 |
Why?
|
| Onions | 1 | 2021 | 10 | 0.040 |
Why?
|
| Europe | 1 | 2021 | 115 | 0.040 |
Why?
|
| Asia | 1 | 2021 | 98 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2021 | 63 | 0.040 |
Why?
|
| Iontophoresis | 1 | 2020 | 10 | 0.040 |
Why?
|
| Electroporation | 1 | 2020 | 21 | 0.040 |
Why?
|
| Equipment Design | 1 | 2020 | 145 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 102 | 0.040 |
Why?
|
| Disease Progression | 1 | 2022 | 667 | 0.040 |
Why?
|
| Length of Stay | 1 | 2021 | 229 | 0.040 |
Why?
|
| Premature Birth | 1 | 2021 | 95 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2023 | 638 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 173 | 0.040 |
Why?
|
| Hemorheology | 1 | 2018 | 25 | 0.030 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2017 | 7 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2021 | 972 | 0.030 |
Why?
|
| K562 Cells | 1 | 2017 | 32 | 0.030 |
Why?
|
| Vaccines, Conjugate | 1 | 2017 | 9 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2017 | 155 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 204 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 63 | 0.030 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 24 | 0.030 |
Why?
|
| Erythrocyte Deformability | 1 | 2016 | 2 | 0.030 |
Why?
|
| Hela Cells | 1 | 2018 | 376 | 0.030 |
Why?
|
| Phase Transition | 1 | 2016 | 8 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2016 | 15 | 0.030 |
Why?
|
| Muramidase | 1 | 2016 | 30 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2016 | 83 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 278 | 0.030 |
Why?
|
| Polyethyleneimine | 1 | 2015 | 10 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2016 | 118 | 0.030 |
Why?
|
| KB Cells | 1 | 2015 | 7 | 0.030 |
Why?
|
| Diffusion | 1 | 2015 | 63 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 1772 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2015 | 51 | 0.030 |
Why?
|
| Temperature | 1 | 2016 | 313 | 0.030 |
Why?
|
| Chickens | 1 | 2016 | 161 | 0.030 |
Why?
|
| Adenosine | 1 | 2014 | 62 | 0.030 |
Why?
|
| Zinc Compounds | 1 | 2014 | 12 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 278 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 876 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 570 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2014 | 190 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 157 | 0.030 |
Why?
|
| Sulfides | 1 | 2014 | 78 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 84 | 0.020 |
Why?
|
| Glucose | 1 | 2014 | 244 | 0.020 |
Why?
|
| Mice, Hairless | 1 | 2012 | 7 | 0.020 |
Why?
|
| Biochemistry | 1 | 2012 | 12 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2012 | 43 | 0.020 |
Why?
|
| Ileum | 1 | 2012 | 20 | 0.020 |
Why?
|
| Cadmium | 1 | 2012 | 56 | 0.020 |
Why?
|
| Intestines | 1 | 2012 | 71 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 506 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 694 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 160 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 388 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 26 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1124 | 0.020 |
Why?
|
| United States | 1 | 2021 | 5205 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 5080 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 13872 | 0.010 |
Why?
|